Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas

Carbohydrate Polymers

Volumn 121, Issue , 2015, Pages 190-198

  Ghasemi, Zahra ^a   Dinarvand, Rassoul ^a   Mottaghitalab, Fatemeh ^a   Esfandyari Manesh, Mehdi ^a   Sayari, Elmira ^a   Atyabi, Fatemeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 Fluorouracil; Chitosan; Hyaluronan; MUC1 binding aptamer

Indexed keywords

BINS; CELL CULTURE; CHITOSAN; CYTOTOXICITY; ELECTROPHORESIS; ENCAPSULATION; HYALURONIC ACID; TOXICITY;

5-FLUOROURACIL; APTAMERS; CHINESE HAMSTER OVARY CELLS; COLORECTAL ADENOCARCINOMA; CONFOCAL SCANNING MICROSCOPY; ENCAPSULATION EFFICIENCY; HUMAN ADENOCARCINOMA; HYALURONAN;

NANOPARTICLES;

APTAMER; CHITOSAN; FLUOROURACIL; HYALURONIC ACID; MUC1 PROTEIN, HUMAN; MUCIN 1; NANOPARTICLE;

ADENOCARCINOMA; ANIMAL; CHEMISTRY; CHO CELL LINE; COLORECTAL NEOPLASMS; CRICETULUS; GENETICS; HAMSTER; HT 29 CELL LINE; HUMAN; METABOLISM;

ADENOCARCINOMA; ANIMALS; APTAMERS, NUCLEOTIDE; CHITOSAN; CHO CELLS; COLORECTAL NEOPLASMS; CRICETINAE; CRICETULUS; FLUOROURACIL; HT29 CELLS; HUMANS; HYALURONIC ACID; MUCIN-1; NANOPARTICLES;

EID: 84961290383     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.12.025     Document Type: Article

References (24)

1. Arias, J.L., Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules 13:10 (2008), 2340–2369.
2. Bae, Y.H., Park, K., Targeted drug delivery to tumors: Myths, reality and possibility. Journal of Controlled Release, 153(3), 2011, 198.
3. Bertrand, N., Wu, J., Xu, X., Kamaly, N., Farokhzad, O.C., Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews 66 (2014), 2–25, 10.1016/j.addr.2013.11.009.
4. Chang, K., Pi, Y., Lu, W., Wang, F., Pan, F., Li, F., et al. Label-free and high-sensitive detection of human breast cancer cells by aptamer-based leaky surface acoustic wave biosensor array. Biosensors and Bioelectronics 60 (2014), 318–324.
5. Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., et al. Hyaluronic acid–chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials 35:14 (2014), 4333–4344, 10.1016/j.biomaterials.2014.02.006.
6. Dhar, S., Gu, F.X., Langer, R., Farokhzad, O.C., Lippard, S.J., Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proceeding of the National Academy of Science of United States of America 105:45 (2008), 17356–17361, 10.1073/pnas.0809154105.
7. Duceppe, N., Tabrizian, M., Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials 30:13 (2009), 2625–2631, 10.1016/j.biomaterials.2009.01.017.
8. Duncan, R., The dawning era of polymer therapeutics. Nature Reviews Drug Discovery 2:5 (2003), 347–360, 10.1038/nrd1088.
9. Farokhzad, O.C., Cheng, J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proceedings of the National Academy of Sciences of United States of America 103:16 (2006), 6315–6320.
10. Ferreira, C.S., Cheung, M.C., Missailidis, S., Bisland, S., Gariepy, J., Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Research 37:3 (2009), 866–876, 10.1093/nar/gkn967.
11. Ferreira, C.S., Matthews, C.S., Missailidis, S., DNA aptamers that bind to MUC1 tumour marker: Design and characterization of MUC1-binding single-stranded DNA aptamers. Tumour Biology 27:6 (2006), 289–301, 10.1159/000096085.
12. Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32:31 (2011), 8010–8020, 10.1016/j.biomaterials.2011.07.004.
13. Jarmila, V., Vavrikova, E., Chitosan derivatives with antimicrobial, antitumour and antioxidant activities—A review. Current Pharmaceutical Design 17:32 (2011), 3596–3607.
14. Li, P., Wang, Y., Peng, Z., She, F., Kong, L., Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydate Polymers 85:3 (2011), 698–704.
15. Mok, H., Park, J.W., Park, T.G., Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjugate Chemistry 18:5 (2007), 1483–1489.
16. Muzzarelli, C., Stanic, V., Gobbi, L., Tosi, G., Muzzarelli, R.A., Spray-drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres. Carbohydate Polymers 57:1 (2004), 73–82.
17. Muzzarelli, R.A., Greco, F., Busilacchi, A., Sollazzo, V., Gigante, A., Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: A review. Carbohydate Polymers 89:3 (2012), 723–739.
18. Muzzarelli, R.A., Lough, C., Emanuelli, M., The molecular weight of chitosans studied by laser light-scattering. Carbohydrate Research 164 (1987), 433–442.
19. Nizri, G., Magdassi, S., Schmidt, J., Cohen, Y., Talmon, Y., Microstructural characterization of micro- and nanoparticles formed by polymer-surfactant interactions. Langmuir 20:11 (2004), 4380–4385.
20. Oyarzun-Ampuero, F.A., Brea, J., Loza, M.I., Torres, D., Alonso, M.J., Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. International Journal of Pharmaceutics 381:2 (2009), 122–129, 10.1016/j.ijpharm.2009.04.009.
21. Ray, P., White, R.R., Aptamers for targeted drug delivery. Pharmaceuticals 3:6 (2010), 1761–1778.
22. Sayari, E., Dinarvand, M., Amini, M., Azhdarzadeh, M., Mollarazi, E., Ghasemi, Z., et al. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. International Journal of Pharmaceutics 473:1-2 (2014), 304–315.
23. Umerska, A., Paluch, K.J., Inkielewicz-Stepniak, I., Santos-Martinez, M.J., Corrigan, O.I., Medina, C., et al. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers. International Journal of Pharmaceutics 436:1–2 (2012), 75–87, 10.1016/j.ijpharm.2012.07.011.
24. Zhu, L., Ma, J., Jia, N., Zhao, Y., Shen, H., Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: Preparation, characterization and cytotoxicity studies. Colloids and Surfaces B: Biointerfaces 68:1 (2009), 1–6, 10.1016/j.colsurfb.2008.07.020.